Oral paclitaxel with encequidar: The first orally administered paclitaxel shown to be superior to IV paclitaxel on confirmed response and survival with less neuropathy: A phase III clinical study in metastatic breast cancer - Umanzor, G; Cutler, D L; Barrios, F J (Cancer Res, 2020)